Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127065223 | 12706522 | 3 | F | 2016 | 20160912 | 20160901 | 20160915 | PER | US-PFIZER INC-2016407903 | PFIZER | 28.00 | YR | M | Y | 86.17000 | KG | 20160915 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127065223 | 12706522 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | N | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
127065223 | 12706522 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY | N | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127065223 | 12706522 | 1 | Anxiety |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127065223 | 12706522 | Activities of daily living impaired | |
127065223 | 12706522 | Amnesia | |
127065223 | 12706522 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127065223 | 12706522 | 1 | 201605 | 201605 | 0 | |
127065223 | 12706522 | 2 | 201605 | 20160622 | 0 |